| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |